ATE199907T1 - Phosphonat-nukleotid-verbindungen - Google Patents

Phosphonat-nukleotid-verbindungen

Info

Publication number: ATE199907T1
Authority: AT; Austria
Prior art keywords: halogen; alkyl; substituted; phosphonate; alkoxy
Prior art date: 1996-01-18

Application number

AT97100652T

Other languages

English (en)

Inventor

Masaru C O Mitsubishi Ubasawa

Kouichi C O Mitsubishi Sekiya

Hideaki C O Mitsubis Takashima

Naoko C O Mitsubishi Chem Ueda

Satoshi C O Mitsubishi C Yuasa

Naohiro C O Mitsubishi Kamiya

Original Assignee

Mitsubishi Chem Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-18

Filing date

1997-01-17

Publication date

2001-04-15

1997-01-17 Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp

2001-04-15 Application granted granted Critical

2001-04-15 Publication of ATE199907T1 publication Critical patent/ATE199907T1/de

Links

150000001875 compounds Chemical class 0.000 title 1
239000002773 nucleotide Substances 0.000 title 1
229910052739 hydrogen Inorganic materials 0.000 abstract 3
150000002431 hydrogen Chemical class 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
125000000229 (C1-C4)alkoxy group Chemical class 0.000 abstract 1
125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 abstract 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
230000000840 anti-viral effect Effects 0.000 abstract 1
239000003443 antiviral agent Substances 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
125000001495 ethyl group Chemical class [H]C([H])([H])C([H])([H])* 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000000449 nitro group Chemical class [O-][N+](*)=O 0.000 abstract 1
229910052757 nitrogen Chemical group 0.000 abstract 1
-1 phosphonate nucleotide compound Chemical class 0.000 abstract 1
125000002924 primary amino group Chemical class [H]N([H])* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

AT97100652T 1996-01-18 1997-01-17 Phosphonat-nukleotid-verbindungen ATE199907T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP648096		1996-01-18

Publications (1)

Publication Number	Publication Date
ATE199907T1 true ATE199907T1 (de)	2001-04-15

Family

ID=11639647

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97100652T ATE199907T1 (de)	1996-01-18	1997-01-17	Phosphonat-nukleotid-verbindungen

Country Status (12)

Country	Link
US (1)	US5840716A (de)
EP (1)	EP0785208B1 (de)
KR (1)	KR100366727B1 (de)
CN (2)	CN1088712C (de)
AT (1)	ATE199907T1 (de)
CA (1)	CA2195262C (de)
DE (1)	DE69704286T2 (de)
DK (1)	DK0785208T3 (de)
ES (1)	ES2155219T3 (de)
GR (1)	GR3035776T3 (de)
PT (1)	PT785208E (de)
TW (1)	TW369536B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE199906T1 (de) *	1993-06-29	2001-04-15	Mitsubishi Chem Corp	Phosphonat-nukleotid ester-derivate
US6194398B1 (en)	1996-08-13	2001-02-27	Mitsubishi Chemical Corporation	Phosphonate nucleotide compound
US7205404B1 (en)	1999-03-05	2007-04-17	Metabasis Therapeutics, Inc.	Phosphorus-containing prodrugs
CN1426418A (zh)	2000-02-29	2003-06-25	三菱制药株式会社	膦酸酯核苷酸化合物
WO2003028737A1 (en) *	2001-08-30	2003-04-10	Mitsubishi Pharma Corporation	Anti-viral agents and in-vitro method for the identification of candidates able to inhibit binding of polymerase to epsilon
US20040023928A1 (en) *	2001-10-31	2004-02-05	Colacino Joseph Matthew	Phosphonate nucleotide and thiadiazole compounds for the treatment of smallpox
JP2005511749A (ja) *	2001-12-07	2005-04-28	三菱ウェルファーマ株式会社	Ｂ型肝炎ウィルス感染症を治療するためのホスホネートヌクレオチド類似体の使用
WO2003051881A1 (en) *	2001-12-17	2003-06-26	Ribapharm Inc.	Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies
AU2003264417A1 (en) *	2002-09-13	2004-04-30	Mitsubishi Pharma Corporation	Crystal of 2-amino-6-(4-methoxyphenylthio)-9-(2-(phosphonomethoxy)ethyl)purine bis(2,2,2-trifluoroethyl) ester
KR20040042896A (ko) *	2002-11-15	2004-05-20	미쯔비시 웰 파마 가부시키가이샤	의약 제제 조성물
TW200413399A (en) *	2002-11-15	2004-08-01	Mitsubishi Pharma Corp	Process for producing 2-[bis(2,2,2-trifluoroethyl)phosphonylmethoxy]ethyl halide
WO2005090370A1 (en) *	2004-02-05	2005-09-29	The Regents Of The University Of California	Pharmacologically active agents containing esterified phosphonates and methods for use thereof
CN100475825C (zh) *	2004-03-19	2009-04-08	中国人民解放军军事医学科学院毒物药物研究所	无环核苷膦酸酯衍生物
ES2401285T3 (es)	2004-12-16	2013-04-18	The Regents Of The University Of California	Fármacos con el pulmón como diana
CN1827627B (zh) *	2005-03-04	2011-05-11	北京美倍他药物研究有限公司	新的无环核苷膦酸及其酯衍生物及其医药用途
US8642577B2 (en)	2005-04-08	2014-02-04	Chimerix, Inc.	Compounds, compositions and methods for the treatment of poxvirus infections
EP2842559A3 (de) *	2005-04-08	2015-03-18	Chimerix, Inc.	Verbindungen, Zusammensetzungen und Verfahren zur Behandlung viraler Infektionen und anderer Erkrankungen
CA2683316A1 (en)	2007-04-13	2009-02-19	Southern Research Institute	Anti-angiogenic agents and methods of use
CN101293899B (zh) *	2007-04-28	2011-12-07	中国人民解放军军事医学科学院毒物药物研究所	无环核苷膦酸酯衍生物及其医药用途
ES2572631T3 (es) *	2008-01-25	2016-06-01	Chimerix, Inc.	Métodos de tratamiento de infecciones virales
WO2011011519A1 (en)	2009-07-21	2011-01-27	Chimerix, Inc.	Compounds, compositions and methods for treating ocular conditions
CA2770282A1 (en)	2009-08-03	2011-02-10	Chimerix, Inc.	Composition and methods of treating viral infections and viral induced tumors
CN102093422B (zh) *	2009-12-10	2015-02-25	中国人民解放军军事医学科学院毒物药物研究所	无环核苷膦酸酯衍生物及其医药用途
US9006218B2 (en)	2010-02-12	2015-04-14	Chimerix Inc.	Nucleoside phosphonate salts
CA2797601A1 (en)	2010-04-26	2011-11-10	Chimerix, Inc.	Methods of treating retroviral infections and related dosage regimes
CN102286026B (zh) *	2010-06-18	2014-07-02	中国人民解放军军事医学科学院毒物药物研究所	无环核苷酸类似物的盐及其晶型和药物组合物
EP3578563B1 (de)	2011-12-22	2021-04-14	Geron Corporation	Guanin-analoga als telomerasesubstrate und telomerlängenaffektoren
EP2846788A1 (de)	2012-05-11	2015-03-18	Akron Molecules AG	Verwendung von verbindungen zur schmerzbehandlung
SG10201800188SA (en)	2013-03-15	2018-02-27	Univ California	Acyclic nucleoside phosphonate diesters
AU2015217221A1 (en)	2014-02-13	2016-08-11	Ligand Pharmaceuticals, Inc.	Prodrug compounds and their uses
CN106687118A (zh)	2014-07-02	2017-05-17	配体药物公司	前药化合物及其用途
CN111808136B (zh)	2014-09-15	2024-06-11	加利福尼亚大学董事会	核苷酸类似物
EP3350191B9 (de)	2015-09-15	2021-12-22	The Regents of the University of California	Nukleotidanaloga
CA3087932A1 (en)	2018-01-09	2019-07-18	Ligand Pharmaceuticals, Inc.	Acetal compounds and therapeutic uses thereof
KR20250052378A (ko)	2022-07-21	2025-04-18	안티바 바이오사이언시즈, 인크.	Hpv 감염 및 hpv-유도 신생물의 치료를 위한 조성물 및 투여 형태

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9020932D0 (en) *	1990-09-26	1990-11-07	Wellcome Found	Heterocyclic compounds
US5532225A (en) *	1992-07-31	1996-07-02	Sri International	Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods
EP0618214A1 (de) *	1993-04-01	1994-10-05	Merrell Dow Pharmaceuticals Inc.	Ungesättigte Phosphonatderivate Purinen und Pyrimidinen
ATE199906T1 (de) *	1993-06-29	2001-04-15	Mitsubishi Chem Corp	Phosphonat-nukleotid ester-derivate

1997
- 1997-01-16 CA CA002195262A patent/CA2195262C/en not_active Expired - Fee Related
- 1997-01-16 TW TW086100424A patent/TW369536B/zh active
- 1997-01-17 DE DE69704286T patent/DE69704286T2/de not_active Expired - Fee Related
- 1997-01-17 DK DK97100652T patent/DK0785208T3/da active
- 1997-01-17 ES ES97100652T patent/ES2155219T3/es not_active Expired - Lifetime
- 1997-01-17 AT AT97100652T patent/ATE199907T1/de not_active IP Right Cessation
- 1997-01-17 US US08/785,606 patent/US5840716A/en not_active Expired - Fee Related
- 1997-01-17 EP EP97100652A patent/EP0785208B1/de not_active Expired - Lifetime
- 1997-01-17 PT PT97100652T patent/PT785208E/pt unknown
- 1997-01-18 KR KR1019970001362A patent/KR100366727B1/ko not_active Expired - Fee Related
- 1997-01-18 CN CN97103169A patent/CN1088712C/zh not_active Expired - Fee Related
2001
- 2001-04-23 GR GR20010400489T patent/GR3035776T3/el not_active IP Right Cessation
2002
- 2002-03-28 CN CN021085013A patent/CN1216060C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1216060C (zh)	2005-08-24
PT785208E (pt)	2001-06-29
CN1164534A (zh)	1997-11-12
KR100366727B1 (ko)	2003-03-15
US5840716A (en)	1998-11-24
CA2195262C (en)	2005-08-09
DE69704286T2 (de)	2001-10-25
EP0785208A1 (de)	1997-07-23
CN1088712C (zh)	2002-08-07
DE69704286D1 (de)	2001-04-26
DK0785208T3 (da)	2001-04-23
KR970059181A (ko)	1997-08-12
CA2195262A1 (en)	1997-07-19
ES2155219T3 (es)	2001-05-01
EP0785208B1 (de)	2001-03-21
TW369536B (en)	1999-09-11
GR3035776T3 (en)	2001-07-31
CN1398864A (zh)	2003-02-26

Legal Events

Date	Code	Title	Description
2001-08-15	UEP	Publication of translation of european patent specification
2006-10-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69704286D1 (de)	2001-04-26	Phosphonat-Nukleotid-Verbindungen
TW370450B (en)	1999-09-21	Substituted 1H-3-aryl-pyrrolidine-2,4-dione derivatives
AU1282495A (en)	1995-07-17	Anthranilic acid derivative
DK0918776T3 (da)	2004-07-12	Totalsyntese af antitumor acylfulvener
DE60228316D1 (en)	2008-09-25	Xanthinoxidaseinhibitoren
DK1113011T3 (da)	2006-11-27	Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
ES2142773A1 (es)	2000-04-16	Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
TW427979B (en)	2001-04-01	A condensed piperidine compound
DK1031556T3 (da)	2003-02-24	2-phenoxyanilinderivater
MX9701949A (es)	1997-06-28	Derivados de distamicina substituidos con bis-(2-haloetil) aminofenilo como agentes antitumorales y antivirales.
AU9025601A (en)	2002-04-02	Cephem compounds and esbl-detecting reagents containing the same
DE69612967D1 (en)	2001-06-28	Optisch aktive thiazolidinonderivate
TW356471B (en)	1999-04-21	Novel carbocyclic nucleoside agents useful as selective inhibitor of proinflammatory cytokines
ATE192741T1 (de)	2000-05-15	Pyridazinon-derivate
CA2419463A1 (en)	2002-03-07	Primary intermediates for oxidative coloration of hair
AU5660598A (en)	1998-07-17	Use of aminoisothiazoles as microbicides
EG24798A (en)	2010-09-15	Pyrazole compound.
EP0443474A3 (en)	1992-04-22	1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
BR9305092A (pt)	1994-08-16	Processo para a preparação de derivados de 5-pirazolmercáptan, composto ditiocarbazato de etilideno, processo para a preparação de derivados do mesmo
WO1997003082A3 (en)	1997-02-27	Pyrimidine nucleoside derivatives